Rock Springs Capital Management LP Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$4.0T
Holdings
135
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (135 positions)
| Stock | Value |
|---|---|
—ICOSAVAX INC | $5.4M |
BMEABIOMEA FUSION INC | $5.2M |
—PARATEK PHARMACEUTICALS INC | $5.1M |
—THESEUS PHARMACEUTICALS INC | $5.0M |
INZYINOZYME PHARMA INC | $4.9M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $4.7M |
FATEFATE THERAPEUTICS INC | $4.3M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $4.2M |
CGENCOMPUGEN LTD | $4.2M |
—EQRX INC | $4.1M |
—KINNATE BIOPHARMA INC | $3.9M |
—PHASEBIO PHARMACEUTICALS INC | $3.5M |
TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | $3.4M |
OKURRENEO PHARMACEUTICALS INC | $3.4M |
VIGLVIGIL NEUROSCIENCE INC | $3.3M |
TCE2CELLDEX THERAPEUTICS INC NEW | $3.3M |
SPRBSPRUCE BIOSCIENCES INC | $3.3M |
—VINCERX PHARMA INC | $3.3M |
EPIEURESSA PHARMA INC | $3.2M |
—BCLS ACQUISITION CORP | $3.0M |
OVASUSDTEMPEST THERAPEUTICS INC | $2.8M |
—F-STAR THERAPEUTICS INC | $2.7M |
PRLDPRELUDE THERAPEUTICS INC | $2.5M |
—JIYA ACQUISITION CORP | $2.0M |
—ACELRX PHARMACEUTICALS INC | $1.8M |
—IMARA INC | $1.6M |
APLTAPPLIED THERAPEUTICS INC | $1.5M |
—RADIUS HEALTH INC | $1.5M |
BCELATRECA INC | $1.5M |
—THERAVANCE BIOPHARMA INC | $1.4M |
STTKSHATTUCK LABS INC | $1.3M |
NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | $1.3M |
PSTXUSDPOSEIDA THERAPEUTICS INC | $1.3M |
NVRO 2.75 04/01/25NEVRO CORP | $541K |
NUVB/WSNUVATION BIO INC | $108K |
PreviousPage 2 of 2